Auris Medical : development of novel pharmaceutical therapies to prevent or treat severe inner ear disorders like tinnitus and hearing loss

 

 

SEC Filing Details

Document Details

Form
EFFECT
Filing Date
Mar 27, 2019
Document Date
Mar 27, 2019
Form Description
EFFECT
Filing Group
Other
Company
Auris Medical Holding Ltd.

Investors